Showing posts with label Bipolar Disorder. Show all posts
Showing posts with label Bipolar Disorder. Show all posts

Sunday, May 6, 2012

SWSLHD and Bowral's Health - 62

Nicotine patches concern for bipolar patients - ■ Kate Cowling - 6Minutes

Caution should be exercised when prescribing nicotine replacement therapies for patients with mental illness, psychiatrists warn, after a patch appeared to trigger a manic episode in a man with bipolar disorder.

Their case report documents the mental deterioration of a 35-year-old man who had a history of bipolar disorder but no “unremarkable” lifestyle changes, except for recently quitting smoking and commencing maximum (21 mg) strength nicotine patches.

After starting the patches, the patient was unable to sleep, became irritable and showed uncontrollable anger and physically aggression, the authors write in the Australia and NZ Journal of Psychiatry.

“The quick resolution of his manic symptoms on a relatively low dose of quetiapine and with the cessation of nicotine patches... suggested a possible correlation between excessive nicotine levels and the precipitation of a manic episode,” they say.

Nicotine may have triggered mania by disrupting the patient’s sleep/wake cycle, or possibly through the stimulation of his dopaminergic system, the psychiatrists suggest.

“The understanding of this potential risk is of clinical relevance given increased use of nicotine patches after the implementation of the non-smoking policy within health settings,” they say.

They add it also highlights the importance of educating patients about potential stimulant and/or overdose effects of nicotine patches.

Tuesday, November 1, 2011

SWSLHD and Bowral's Health - 48

A meaty question when it comes to mental health


Medical Observer

PEOPLE who don’t eat much red meat may be susceptible to mental disorders such as depression, but eating too much red meat has a similar effect, research shows.

Researchers from Deakin University showed that among 1000 randomly selected women, those who ate both less, and more, red meat than recommended by Australian dietary guidelines, were twice as likely to have major depression or dysthymia.

The results, presented at last week’s conference, remained significant after adjusting for overall healthy diet.

Similarly, women who ate less than the recommended amount of red meat were 15 times more likely to have bipolar disorder, and those eating more were eight times more likely to have bipolar disorder.

Women who ate less red meat were also nearly twice as likely to have an anxiety disorder.

Lead author Dr Felice Jacka, NHMRC research fellow at the Barwon Psychiatric Research Unit at Geelong Hospital and Deakin University, said recognition of the role diet played in mental health was low.

“It’s certainly not part of any clinical guidelines or recommended clinical practice at this point but we think it should be based on the clinical consistency of the evidence,” she said.

Comments:


Docmus
26th Oct 2011
8:31pm
Interesting observation but you have to wonder about the reliability of the study. Is 1000 women enough to conclude anything when the number of actual bipolar cases will be pretty small? How can the women be randomly selected when a substantial number will surely decline to take part in long quizzes about diet and mental health history? The confounding variables in this study would be almost insurmountable.
 
FeliceN
26th Oct 2011
8:56pm
Hi Docmus
I wish to clarify - unfortunately my quote on this study was taken out of context. We have previously published both cross-sectional and prospective studies of the link between diet quality and mental health, and this is what I referred to as clinical consistency of the evidence (ie. regarding diet quality, not red meat). This particular report on red meat (whilst assessing confounding by other factors) did have very small numbers of BD cases and I have urged caution in over-interpreting our findings. They are very preliminary and need to be replicated before any recommendations can be made.

SWSLHD and Bowral's Health - 47

Zealously over or under?


Medical Observer

Has the effort to correct the problem of underdiagnosis of bipolar disorder shifted too far in the opposite direction? Lynnette Hoffman reports.


LAST spring two parents in a seaside village in Massachusetts were convicted of murdering their four-year-old daughter by administering a lethal combination of a high dose of clonidine and an antihistamine.1,2

The little girl, Rebecca Riley, had been diagnosed with bipolar disorder at the age of two, and along with clonidine, she’d also been taking the antipsychotic quetiapine and the mood stabiliser divalproex sodium (not available in Australia).

But as details of the case emerged, it wasn’t just the actions of the girl’s parents that had people concerned.

Earlier this year the psychiatrist who made the diagnosis and prescribed the medications settled a medical malpractice case for $2.5 million, which will go to the girl’s two siblings, who had also been diagnosed with bipolar disorder.3

Court testimony portrayed the psychiatrist as having been duped into a diagnosis of bipolar disorder by cunning parents who wanted to silence their children. After the girl’s death the psychiatrist voluntarily stopped practising, but the licensing board permitted her to resume practice and she is now back at work.

It’s an extreme example of a diagnosis gone wrong, and so far no such cases have cropped up in Australia. But some psychiatrists say that while we haven’t reached those extremes, there is a worrying trend toward doctors being persuaded by patients’ own self-diagnosis of bipolar disorder, or desire for immediate treatment – even if there’s not sufficient evidence to support it.

Historically, the biggest concern has been underdiagnosis of bipolar disorder. But Professor Gin Malhi, head of psychological medicine at the University of Sydney and editor of the Australian and New Zealand Journal of Psychiatry, says while cases of bipolar disorder do continue to go unrecognised, overdiagnosis is becoming a problem of equal or possibly even greater proportions.

“I think the threshold for diagnosing bipolar II disorder, in particular, has dropped,” Professor Malhi says.

“The zeal for the underdiagnosis of bipolar disorder has led to overdiagnosis in certain circumstances… It just reflects really that we don’t have a very good mechanism to diagnose, hence we’re losing at both ends.

“People who have clear mania, clearly are bipolar, but there are other kinds of symptoms that can look like mania or overlap with mania.

“The temptation is to define people with depression and very occasional periods of feeling high or elated as having bipolar disorder.”

Another prominent psychiatrist who shares Professor Malhi’s concerns is University of New South Wales professor of psychiatry Philip Mitchell, who articulated the complexities of balancing early but accurate diagnosis in a paper he co-wrote for the MJA last year.4

Professor Mitchell points to an American study published in 2008 in which 700 psychiatric outpatients at a hospital in Rhode Island were interviewed with the Structured Clinical Interview for DSM-IV (SCID).5

Less than half the patients who had previously been diagnosed with bipolar disorder by a health professional received that diagnosis based on the SCID test.

Data collected about their family history (which those diagnosing were blinded to) showed that patients with SCID-diagnosed bipolar disorder had a significantly higher morbid risk of bipolar disorder than patients who self-reported a previous diagnosis of bipolar disorder not confirmed by the SCID.

In fact, patients who told doctors they had bipolar disorder, which was not diagnosed using SCID, had the same morbid risk for bipolar disorder as those patients without bipolar disorder.

Like Professor Malhi, Professor Mitchell believes that patients are being diagnosed who don’t fulfil the criteria, “even broad criteria”.

Whereas traditionally the criteria for diagnosing a hypomanic episode consisted of at least 2–4 days of elevated mood, that has been expanded to encompass a few hours or a day of elevated mood, Professor Mitchell says.

“A number of websites around the world have these checklists based on the Mood Disorder Questionnaire, so patients are incorrectly labelling periods of normal enthusiasm and excitement as hypomania.

“They’re coming to their doctors saying ‘I have bipolar disorder’, so I think the problem is patients are self-diagnosing and I think medical practitioners need to be much more critical… Clinicians need to use their own skills and judgement,” he says.

Both experts say more context is needed to diagnose bipolar disorder and doctors need to use their clinical judgement and be critical, rather than treating the DSM-IV as an authoritative checklist.

They say that while certain characteristics may indeed raise the risk of bipolar disorder, they should be treated as such – and monitored closely with a longitudinal approach rather than jumping into treatment prematurely.

However, it would be misleading to claim the views of specialists such as Professors Mitchell and Malhi are unanimous in the field.

Professor Gordon Parker, executive director of the Black Dog Institute, has written numerous papers about the dangers and prevalence of unrecognised bipolar disorder, and he is among those who say the broader criteria still produces accurate results.

“The current duration of mandated highs in the DSM does not accord with clinical observation, and many studies are showing that brief highs of a day or so do not differ by severity or clinical features from highs lasting a week or longer,” Professor Parker says, pointing out that the DSM-5 is set to reduce the criteria for minimum duration as well.

Along with distinctive highs, above and beyond normal happiness, Professor Parker says features such as a ‘bulletproof’ lack of anxiety, as well as the patient’s retrospective awareness of the consequences – such as spending large amounts of money or major sexual indiscretions – and the feelings of guilt and shame that follow, are among the features that differentiate hypomania.

As for the Mood Disorders Questionnaire and Mood Swings Questionnaire screen tests, when used in patients with depression (as opposed to the general community) their accuracy for bipolar disorder is about 80%, Professor Parker says.

“Bipolar II disorder possesses categorical mood-related features that are distinct from normal happiness and unhappiness.

“It is associated with the highest suicide rate of all psychiatric conditions – largely reflecting failures to diagnose.”

Professors Malhi and Mitchell don’t dispute the importance of timely and accurate diagnosis of bipolar disorder.

But they say the problems associated with overdiagnosis are not merely academic.“Bipolar disorder is a serious diagnosis with stigma attached, and the side effects of medications can be quite severe – so you want to be sure that only those patients who need them, get them,” Professor Mitchell says.

“Patients [with broadly defined mania symptoms] will be given the same medications as patients are given for clear bipolar disorder. The difficulty with these lower thresholds is there’s no evidence that these patients actually benefit from the mood stabilisers.”

Making a bipolar disorder diagnosis*

For patients experiencing a major depressive episode with no clear prior episodes of hypomania or mania, Professor Mitchell and his colleagues recommend doctors forgo making an immediate diagnosis and instead take a “probabilistic approach” looking at specific features that indicate greater risk of developing bipolar disorder. These include:

- Depressed patients with an ambiguous past history of hypomanic or manic episodes

- ‘Unipolar depressed’ patients with a family history of bipolar disorder

- Young patients presenting with recurrent depressive episodes only (where it is unclear whether this represents a first presentation of bipolar disorder or unipolar depression)

- “At present, we do not recommend that clinicians immediately diagnose and treat depressed patients with these features as definitely having bipolar disorder, but commend practitioners to seriously consider this possibility for such individuals as treatment progresses,” the authors write.

Further, they recommend watching closely for early warning signs of manic or depressive episodes.

Possible warning signs for manic episodes:

- Increased activity and busyness

- Reduced need for sleep

- Impulsive behaviour

- Speaking in a caustic manner

- Telephoning friends indiscriminately.

Possible warning signs for depressive episodes:

- Feeling tearful, moody, withdrawn, snappy, slowed down, negative, stubborn, pessimistic, hopeless or excessively self-doubting

*MJA 2010; 193: S10–S13
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comments
 
 
 
 
 
 

 
 
Babyteeth
27th Oct 2011
2:23am

The only thing the Drs have cleared up here for certain, is that the Psychiatrists don't have a clue.
Anyone with a severe Depression should be considered a possible manic depressive. The other component is the patient has a charged personality.....many of the characteristics described here are of the difficult person, or maybe agitated or irritated person....As the Psychiatrists have no diagnostic ability at Personality Disorders, how are they ever going to categorise everything else......MDP has become a cover diagnosis, because if you have MDP you are seen as a high achiever and a genius. No wonder the Diagnosis is so attractive to Psychopaths and other Megalomaniacs.... I don't use the label BPD because I don't know what it means anymore.

Sunday, April 10, 2011

SSWAHS = SWSLHN and mental health in the Southern Highlands - 9

Brain volume declines with antipsychotic use

15th Feb 2011
Catherine Hanrahan all articles by this author

THE largest and longest study linking the use of antipsychotics to the loss of brain volume has Australian experts divided over the impact of early treatment initiation.

The Iowa Longitudinal Study found the use of antipsychotics was correlated with smaller brain volume after controlling for illness severity, duration of follow-up and substance misuse.

The prospective study, which followed 211 patients with schizophrenia for a median seven years, found higher doses of antipsychotics were associated with smaller brain volume on MRI.

Professor Louise Newman, developmental psychiatrist at Monash University, said the study should flag the need for caution when initiating antipsychotics.

“It suggests very careful consideration of antipsychotic use before we have clearly established symptoms [in individuals],” she said.

The publication of the Iowa study coincides with a British Journal of Psychiatry editorial by Dr Joanna Moncrieff, co-chair of the UK’s Critical Psychiatry Network. She cites mounting evidence that antipsychotics are linked to brain volume reduction, suggesting early use in young people is not justified.

But Professor Patrick McGorry, executive director of Australia’s Orygen Youth Health, said there was no consensus on the clinical significance of brain volume changes. “It would be very destructive to say that just because the brain issue is not clear, young people shouldn’t get any help,” he said.

Professor David Le Couteur, president of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, said the relevant clinical outcome was long-term cognitive effects.

“[Let’s] see whether these changes in brain volume, which are just a surrogate marker, in fact pan out to have an impact clinically,” he said.

Arch Gen Psychiatry 2011; 68:128-37; B J Psychiatry 2011; 198:85-87

Comments:

big bug
15th Feb 2011
7:06pm


Brain shrinkage in drug-treated psychotic patients (both scz and bipolar) is in no way caused by the genes (which are only for mild schizotypy and benign hypomania). The most likely cause is persistently fatty diet--especially chocolate and cheese--often aggravated by co-morbid anxiety (cortisol alone can shrink the hippocampus, given time). The anxiety--about half of this population--comes from fatty maternal diet, in pregnancy, which also promotes gestational diabetes (which, alone, raises scz risk for offspring SEVEN FOLD). Fatty personal diet, which causes the typical insulin resistance in scz, seems to precipitate acute psychotic episodes, by causing brain inflammation--as in depression. The problem with antipsychotic drugs is that they can increase appetite--for fatty foods already on the menu. The result will be weight gain, diabetes, vascular risk, treatment resistance and a shortened lifespan. Drug-based psychiatry has a poor future. Drug-free management of first-episode psychosis at Soteria House in California led to more patients being employable, after 12 months, compared with hospital-treated cases. To convert scz back to the pure, harmless schizotypy phenotype, use a strict low-fat diet, and for co-morbid anxiety use Inositol supplement 5 gm/day. Using this regimen, I now have 5 formerly scz patients showing obvious improvements in cognition and insight, whose drug doses may now be reduced safely, and even stopped.

Amateur Observer

20th Feb 2011
2:47pm


"Big bug" having just searched the medical literature, I can find no randomized controlled trial of low-fat diet as a treatment. There are also several studies suggesting NO benefit of inositol in chronic schizophrenia. Can you confirm that you practice evidence-based medicine?

sceptical

17th Feb 2011
12:24pm


With all due respect to those who are attempting to treat young schizos, bi-polars, uni-polars, anxiety, we have not been told about the social habits of these unfortunate young people. Perhaps recreational substances use, including alcohol from the legal age of 18 (binge-drinking excluded), are the cause of many falling prey to these mental health disorders?

Amateur Observer

20th Feb 2011
2:52pm


Agree - with almost 100% of schizophrenics being cigarette smokers one would have to be suspicious of nicotine having a role in the pathogenesis (in susceptible individuals).

Richard Cranium

21st Feb 2011
3:48pm


I appreciate your viewpoint Big bug. To Amateur Observer, who would fund a randomized controlled trial of a low fat diet anyway? Who funded the several studies suggesting NO benefit of inositol in chronic schizophrenia? I know on the two occasions I have commented on your comments I have asked you to answer questions but I don't get how someone who is seemingly scientifically minded doesn't ask them also.

It is up to each and every scientist (and I'm not but I am definitely interested) to ask the questions: "Says who and why do they say it?" I'm sure those who take the time to look in to it will find out that there are a number of ways to skin a cat and that some are more humane than others so even if it takes longer and costs more, it's better!

Richard Cranium

21st Feb 2011
3:58pm


I appologise Amateur Observer, it was not your comment I commented on last time, it was a comment made by "Another amateur observer", honest mistake.

big bug

21st Feb 2011
7:53pm


To Amateur Observer: Science, said Charles Darwin, consists in grouping facts, so that general laws and conclusions may be drawn from them. Medicine, with no intellectual appetite for nutritional and epidemiological facts, can do no grouping, so cannot explain or prevent disease, but manages to eke out a living on a meagre diet of Random-allocation Controlled Trials. If you want an RCT of healthy (probably low-fat) diet in scz, check Sherryn Evans, 2005 ("evans s and schizophrenia" on PubMed). Her intensive diet group (in Melbourne!) gained only 2 kg in 6 months on Zyprexa, and reported better energy and mental contentment than the control group given minimal diet advice, who gained 9 kg. We know that fatty diet causes diabetes (H Himsworth, CLIN SCI, 1936: The Diet Of Diabetics Prior To The Onset Of The Disease); that glucose intolerance is common in scz (first reported in 1924); and that scz cases do eat fatty diets (several reports), and often develop diabetes. Malcolm Peet, in the UK, claims to have observed worse scz symptoms when the diet is low in polyunsaturated fatty acids, which agrees with studies showing that sat fats impair cognition, reduce dendritic branching, lower BDNF levels in hippocampus, and cause brain inflammation.
As for Inositol, 2 studies in Israel showed no improvement in ANERGIC (deficit cases--untreatable?) scz cases, given Inositol for only 4 weeks, so longer trials are a must, in more typical cases. Inositol has two potential uses in scz: to treat co-morbid anxiety (up to 65% of cases); and to provide specific anti-ageing benefits (J Barger, 2008) for brain, already shown in caloric restriction animal models--increased neurotrophins like BDNF (to enhance synapse formation and plasticity), increased antioxidant enzymes, enhanced neuronal energy (got to be good!), and increased autophagy and replacement of oxidation-damaged mitochondria. NHMRC-funded low fat diet trials are planned for depression and bipolar in Geelong (Prof M Berk), and clearly should be extended to scz as well.

Amateur Observer

25th Feb 2011
5:28pm


I believe the assertion that "Medicine ... no intellectual appetite for nutritional and epidemiological facts ..." is completely false. And respectfully, the criticism of "medicine managing to eke out a living on RCTs" won't earn you much support here in a GP website!

Surprisingly you didn't even mention the one herbal therapy which has good evidence in reducing actual schizophrenia symptoms (ginseng), but strung together a hodge podge of nearly-related studies not supporting your original view. Regarding glucose-intolerance, this is also an unfortunate, but well-known side effects of common anti-schizophrenia medications (eg Olanzepine) thus the obvious "chicken or the egg?" question.

Sunday, April 3, 2011

SSWAHS = SWSLHN and mental health in the Southern Highlands - 4

Bipolar disorder unrecognised in many depressed patients

8th Mar 2011
Lynnette Hoffman all articles by this author

AT LEAST one in 30 patients who are currently being treated for unipolar depression may have unrecognised bipolar disorder, a UK-based study of primary care patients suggests.

Australian experts said the results were likely to be relevant here, and highlighted the importance of screening all patients who present with depressive symptoms.

Professor Gordon Parker, director of the Black Dog Institute, Sydney, and Dr Paul Morgan (PhD), deputy director of Sane Australia, said the majority of missed cases were likely bipolar II.

“The interval from the onset of symptoms to diagnosis is 10 to 20 years,” Professor Parker said.

“People tend to enjoy their highs and they only come along when they’re depressed. They don’t talk about the highs, and often they’re not asked about them.”

Dr Morgan said more than one-half of patients who have bipolar disorder were originally misdiagnosed with something else and were often prescribed antidepressants rather than a mood stabiliser.

Antidepressants “may be unhelpful by causing suicidal behaviour, treatment resistance and more frequent cycling of mood episodes”, the study authors wrote.

The Australian experts said tools such as the self-test on the Black Dog website or the Mood Disorder questionnaire could assist in screening, but patient history and asking “pointed questions” was vital.

Br J Psychiatry 2011, in press